Fierce Pharma

DECEMBER 8, 2023

It’s also the first medicine using the revolutionary CRISPR gene-editing system, which earned its inventors a Nobel Prize in 2020 and holds tantalizing potential to cure diseases for which there is no treatment.

FDA 319

FDA Medicine Pharmaceutical 319

Fierce Pharma

SEPTEMBER 20, 2024

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday. That changed Friday.

FDA 220

FDA Patients 220

Fierce Pharma

FEBRUARY 20, 2024

It’s been 15 years since Genzyme began rationing the Fabry disease treatment Fabrazyme after a shortage caused by contamination at a manufacturing site, marking the start of many years of litigatio | Sanofi's Genzyme was accused of causing injuries after contaminated doses of its Fabry disease drug led to a shortage, during which the company rationed (..)

Manufacturing 147

Manufacturing 147

World of DTC Marketing

JULY 9, 2021

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” ” From 2016 to 2020, compensation for the 14 companies’ top executives totaled $3.2 The drug industry is driven by profits, not by patient’s needs.

Pharma 292

Pharma FDA Leads Competition 292

Fierce Pharma

JUNE 26, 2024

The loss of patent protection on Amarin’s sole commercial product Vascepa in 2020 has led to a roller coaster ride for the Dublin-based company over the past few years. Amarin is getting a fresh shot to challenge Hikma Pharmaceuticals’ generic version of its fish oil-derived heart med in the lower courts. business.

Pharmaceutical 257

Pharmaceutical 257

Fierce Pharma

MAY 28, 2024

Since NS Pharma launched its Duchenne muscular dystrophy (DMD) drug Viltepso (viltolarsen) in 2020, sales have steadily

Pharma 215

Pharma Sales 215

Fierce Pharma

OCTOBER 22, 2024

The 2020-approved breast cancer med booked $17.9 MacroGenics’ first commercial product, breast cancer drug Margenza, is heading off to TerSera Therapeutics through a $40 million hand-off. | million in 2023 sales as it struggled to make a mark in the crowded market.

Sales 229

Sales Marketing 229

World of DTC Marketing

MAY 2, 2021

According to data from KFF’s annual survey of employers , between 2010 and 2020, insurance premiums for employer-sponsored family coverage rose by 55 percent; the employer’s contribution went up 61 percent. On a percentage basis, the figure for 2020 was Independence’s highest profit margin since 2011, records show.

Healthcare 277

Healthcare Healthcare Insurance Government 277

Fierce Pharma

JUNE 25, 2024

< | The deal with the Israel Tax Authority wraps up pending litigation over taxes payable from 2008 to 2020. With an agreement to make payments totaling $750 million over the next five years, Teva can wipe its slate clean of litigation from Israeli regulators that concerns over a decade's worth of taxes.<

236

236

Fierce Pharma

DECEMBER 20, 2023

In 2020, Palatin Technologies paid $12 million to regain the rights in North America to its struggling female libido drug Vyleesi. | In 2020, Palatin paid $12 million to regain the rights in North America to its struggling female libido drug Vyleesi.

Medicine 211

Medicine Marketing 211

Fierce Pharma

JULY 6, 2023

GSK’s Cabenuva made history in 2020 as the world’s firs | GSK's long-acting Cabenuva is currently approved only as a switch therapy for patients who already have undetectable HIV levels in the blood. Trying to reach some tough populations who have difficulty adhering to existing daily oral therapies, GSK is getting creative.

Patients 246

Patients 246

World of DTC Marketing

AUGUST 26, 2020

However, in both surveys, telehealth visits were perceived as more convenient than office visits (47% in May 2019 vs. 56% in June 2020).

Pharma reps 237

Pharma reps Pharma Rep Doctors Physicians 237

Fierce Pharma

MAY 16, 2024

After admitting to the crime four years ago, a former Sandoz executive will avoid hard time for his part in a generic drug price-fixing scheme. | Hector Kellum agreed to cooperate with federal investigators in 2020, admitting his part in a massive generics price-fixing scheme that spanned many companies.

215

215

Fierce Pharma

JUNE 30, 2023

The Securities and Exchange Commission (SEC) has revealed insider trading charges against five—including former Alexion Vice President | The SEC has revealed insider trading charges against five—including former Alexion vice president Joseph Dupont and a Massachusetts police chief—who allegedly took advantage of prior knowledge of Alexion’s 2020 acquisition (..)

Pharmaceutical 226

Pharmaceutical 226

Fierce Pharma

JULY 13, 2023

billion in 2020 to a projec | A phase 3 study has shown that a new, subcutaneous version of Roche's Ocrevus has proven to be non-inferior to the current infused treatment as measured by the level of drug in the blood, 12 weeks after administration. With the multiple sclerosis market growing rapidly—from $18.9

Marketing 228

Marketing Patients 228

World of DTC Marketing

OCTOBER 21, 2020

2020 trend concept. Hand flip wood cube change year 2019 to 2020. In my opinion, this is due to pharma being sold on programmatic and the lack of investment in creative. 9ine: Searches for specific medical terms have increased, indicating that people don’t necessarily understand common medical terms.

Media 287

Media Pharma Medical Safety 287

Fierce Pharma

FEBRUARY 6, 2024

Incyte previously bought into a Monjuvi collaboration for $750 million ahead of the drug's 2020 approval. . | While Incyte gained more rights to lymphoma med Monjuvi, Novartis claimed the rest of MorphoSys for €2.7B

185

185

Fierce Pharma

NOVEMBER 26, 2024

Now, the manufacturing arriviste—which was founded in 2020—is expanding its production network again with the acquisition of Switzerland's Baccinex, which specializes in fill and finish services.

Specialization 190

Specialization Networking Pharma Manufacturing 190

World of DTC Marketing

JUNE 14, 2022

According to a new report , life expectancy in the United States took another hit in 2021, furthering a dramatic decline from 2020 that was the largest since World War II. years in 2020 and 76.60 In contrast, peer countries averaged a smaller decrease in life expectancy between 2019 and 2020 (0.57 years in 2019 to 76.99

Doctors 176

Doctors Insurance Healthcare Healthcare 176

World of DTC Marketing

JANUARY 4, 2022

billion in 2020 (2020 U.S. Newly approved cancer drugs cost an average of $10,000 per month, with some as high as $30,000 per month. Just over a decade ago, the standard was $4,500. National costs for cancer care were estimated to be $190.2 billion in 2015 and $208.9 population.

Insurance 273

Insurance Transportation Medical Medicine 273

World of DTC Marketing

FEBRUARY 8, 2022

According to the Lancet, a medical journal, the incidence of depression and anxiety has soared in the pandemic—by more than 25% globally in 2020. In October 2020, hackers who had breached Vastaamo, a famous Finnish startup, began blackmailing its users. But are they safe and effective?

Marketing 241

Marketing Doctors Medical Patients 241

Fierce Pharma

JULY 26, 2023

After triumphing over Novartis’ Cosentyx in a 2020 psoriasis study, Skyrizi has dished out another serving of competitor-busting data. AbbVie's Skyrizi has dished out another serving of competitor-busting data, this time going head-to-head against Amgen’s Otezla.

171

171

Fierce Pharma

JULY 25, 2023

Hopes around FibroGen’s anemia drug roxadustat were high in early 2020 when Enrique Conterno arrived as the company’s new CEO. Enrique Conterno has resigned from the FibroGen CEO post for “personal reasons,” the company said Tuesday.

Specialization 185

Specialization 185

World of DTC Marketing

JANUARY 10, 2022

A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3 2020 was a massive year for biotech venture financing – and 2021 has already eclipsed it. VCs prefer to fund companies that already seemed like a sure bet – in other words, were far along.

Food and Drug Administration 213

Food and Drug Administration Pharma Marketing Food 213

World of DTC Marketing

MARCH 17, 2021

By the look of 2020’s results, he’s on the right track—and his compensation shows it. For 2020, AbbVie’s handing its longtime CEO $24 million in total pay, up from 2019’s $21.6 million, the company disclosed in a proxy filing” No biosimilar will take on Humira’s $16 billion in 2020 U.S.

Pharma 186

Pharma Competition Prescription Sales 186

World of DTC Marketing

JULY 6, 2022

The health sector led the federal and state lobbying spending in 2021, continuing a trend from 2019 and 2020. Once again money rules.

Pharma 238

Pharma Distribution Prescription Doctors 238

Clarivate

JUNE 21, 2022

Two novel events drove the 2020 data: the inclusion of Early Access content in the JCR for the first time, and the sudden appearance of COVID-19 as an entirely new, extremely urgent field of study. These factors made the 2020 data explored in last year’s release particularly unusual.

Prospecting 138

Prospecting Medical science Medicine Distribution 138

Fierce Pharma

OCTOBER 24, 2023

Under a 2020 collaboration with MyoKardia, LianBio has held Asian rights to the potential blockbuster cardio drug mavacamten. LianBio originally held the med's Asia commercialization rights under a 2020 collaboration with MyoKardia, which was later bought by Bristol Myers. Now, BMS is ponying up for those rights.

133

133

World of DTC Marketing

MARCH 21, 2022

Aggregate visit volumes for telehealth and in-person Primary Care visits in October 2020 were 7% lower than the volume of solely in-person Primary Care visits for October 2019. Before and after the onset of the COVID-19 pandemic, Behavioral Health accounted for the most significant share of telehealth visits. On average, in 2021, 57.9%

Marketing 206

Marketing Patients 206

Fierce Pharma

AUGUST 3, 2023

Back in 2020, a surprise manufacturing shortfall led to an import ban of Bristol Myers Squibb’s Abraxane, sold by BeiGene, in China. Back in 2020, a surprise manufacturing shortfall led to an import ban of Bristol Myers Squibb’s Abraxane, sold by BeiGene, in China.

Manufacturing 130

Manufacturing 130

World of DTC Marketing

NOVEMBER 18, 2021

prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 Using pricing data from 2019 and 2020, ICER pegged Humira’s net price increase at 9.6% According to Reuters “drugmakers hiked U.S. billion, a U.S. group that reviews the value of medicines said on Tuesday.

Pharma 202

Pharma Medicine Prescription Manufacturing 202

David Bagga

FEBRUARY 22, 2022

What Candidates Can Learn From Kobe Bryant’s Mentality For Sales Interviews Hey welcome back you guys everyone’s having an awesome work week, so far I hope everyone is having a great start to 2020 I hope everyone’s got that 2020 vision locked in remember.

Sales 130

Sales 130

World of DTC Marketing

MARCH 8, 2022

According to KFF “half of all Part D covered drugs (50% of 3,343 drugs) and nearly half of all Part B covered drugs (48% of 568 drugs) had price increases more significant than inflation between July 2019 and July 2020, which was 1.0%. or more – the current annual inflation rate. .

Media 205

Media Pharma Insurance Prescription 205

MedCity News

AUGUST 25, 2022

Specialty drugs reportedly reached 50 percent of all drug spending in 2020, a figure that has increased significantly over the last decade.

Pharma 133

Pharma Biopharma 133

World of DTC Marketing

DECEMBER 23, 2020

During the first quarter of 2020, the number of telehealth visits increased by 50%, compared with the same period in 2019, with a 154% increase in visits noted in surveillance week 13 in 2020, compared with the same period in 2019. The other variable that has increased at a rapid rate is telehealth.

Prescription 249

Prescription Doctors Side effects Marketing 249